New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 16, 2018 - The FDA approved Pharmacyclic’s Imbruvica (ibrutinib) tablets, which shares the same indications as Imbruvica capsules.
Download PDF
Return to publications
